Sirui R. Yang

71 Xinmin Street
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study.

Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study.

Journal: Rheumatology and therapy

Published: December 17, 2025

Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution.

Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution.

Journal: The Journal of allergy and clinical immunology

Published: June 26, 2025

Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution.

Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution.

Journal: The Journal of allergy and clinical immunology

Published: June 26, 2025

A case of autoinflammatory disease with STAT4 variant and localized scleroderma

A case of autoinflammatory disease with STAT4 variant and localized scleroderma

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: June 15, 2025

Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr/J mice with fewer glucocorticoid side effects.

Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr/J mice with fewer glucocorticoid side effects.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 10, 2024

Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial.

Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial.

Journal: Clinical rheumatology

Published: April 24, 2024

Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study.

Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study.

Journal: Rheumatology (Oxford, England)

Published: April 05, 2023

Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy.

Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy.

Journal: Frontiers in immunology

Published: December 21, 2022

Pathogenic Gene Spectrum and Clinical Implication in Chinese Patients with Lupus Nephritis.

Pathogenic Gene Spectrum and Clinical Implication in Chinese Patients with Lupus Nephritis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 02, 2022

Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis.

Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis.

Journal: Clinical kidney journal

Published: February 27, 2022

Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis.

Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis.

Journal: Lupus

Published: February 09, 2021

Deficiency in the frequency and function of Tr1 cells in IgAV and the possible role of IL-27.

Deficiency in the frequency and function of Tr1 cells in IgAV and the possible role of IL-27.

Journal: Rheumatology (Oxford, England)

Published: June 01, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026